Literature DB >> 20688164

Cerebral cortex structure in prodromal Huntington disease.

Peggy C Nopoulos1, Elizabeth H Aylward, Christopher A Ross, Hans J Johnson, Vincent A Magnotta, Andrew R Juhl, Ronald K Pierson, James Mills, Douglas R Langbehn, Jane S Paulsen.   

Abstract

Neuroimaging studies of subjects who are gene-expanded for Huntington Disease, but not yet diagnosed (termed prodromal HD), report that the cortex is "spared," despite the decrement in striatal and cerebral white-matter volume. Measurement of whole-cortex volume can mask more subtle, but potentially clinically relevant regional changes in volume, thinning, or surface area. The current study addressed this limitation by evaluating cortical morphology of 523 prodromal HD subjects. Participants included 693 individuals enrolled in the PREDICT-HD protocol. Of these participants, 523 carried the HD gene mutation (prodromal HD group); the remaining 170 were non gene-expanded and served as the comparison group. Based on age and CAG repeat length, gene-expanded subjects were categorized as "Far from onset," "Midway to onset," "Near onset," and "already diagnosed." MRI scans were processed using FreeSurfer. Cortical volume, thickness, and surface area were not significantly different between the Far from onset group and controls. However, beginning in the Midway to onset group, the cortex showed significant volume decrement, affecting most the posterior and superior cerebral regions. This pattern progressed when evaluating the groups further into the disease process. Areas that remained mostly unaffected included ventral and medial regions of the frontal and temporal cortex. Morphologic changes were mostly in thinning as surface area did not substantially change in most regions. Early in the course of HD, the cortex shows changes that are manifest as cortical thinning and are most robust in the posterior and superior regions of the cerebrum.
Copyright © 2010 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Year:  2010        PMID: 20688164      PMCID: PMC2955824          DOI: 10.1016/j.nbd.2010.07.014

Source DB:  PubMed          Journal:  Neurobiol Dis        ISSN: 0969-9961            Impact factor:   5.996


  55 in total

1.  Parametric estimate of intensity inhomogeneities applied to MRI.

Authors:  M Styner; C Brechbühler; G Székely; G Gerig
Journal:  IEEE Trans Med Imaging       Date:  2000-03       Impact factor: 10.048

2.  Functional brain changes in presymptomatic Huntington's disease.

Authors:  Sarah A J Reading; Adam C Dziorny; Laura A Peroutka; Mathew Schreiber; Lisa M Gourley; Venu Yallapragada; Adam Rosenblatt; Russell L Margolis; James J Pekar; Godfrey D Pearlson; Elizabeth Aylward; Jason Brandt; Susan S Bassett; Christopher A Ross
Journal:  Ann Neurol       Date:  2004-06       Impact factor: 10.422

3.  Geometrically accurate topology-correction of cortical surfaces using nonseparating loops.

Authors:  Florent Ségonne; Jenni Pacheco; Bruce Fischl
Journal:  IEEE Trans Med Imaging       Date:  2007-04       Impact factor: 10.048

4.  Cortical surface-based analysis. II: Inflation, flattening, and a surface-based coordinate system.

Authors:  B Fischl; M I Sereno; A M Dale
Journal:  Neuroimage       Date:  1999-02       Impact factor: 6.556

5.  Progression of structural neuropathology in preclinical Huntington's disease: a tensor based morphometry study.

Authors:  C M Kipps; A J Duggins; N Mahant; L Gomes; J Ashburner; E A McCusker
Journal:  J Neurol Neurosurg Psychiatry       Date:  2005-05       Impact factor: 10.154

6.  Neuronal loss in layers V and VI of cerebral cortex in Huntington's disease.

Authors:  J C Hedreen; C E Peyser; S E Folstein; C A Ross
Journal:  Neurosci Lett       Date:  1991-12-09       Impact factor: 3.046

7.  In vivo evidence of cerebellar atrophy and cerebral white matter loss in Huntington disease.

Authors:  C Fennema-Notestine; S L Archibald; M W Jacobson; J Corey-Bloom; J S Paulsen; G M Peavy; A C Gamst; J M Hamilton; D P Salmon; T L Jernigan
Journal:  Neurology       Date:  2004-09-28       Impact factor: 9.910

8.  Biological and clinical manifestations of Huntington's disease in the longitudinal TRACK-HD study: cross-sectional analysis of baseline data.

Authors:  Sarah J Tabrizi; Douglas R Langbehn; Blair R Leavitt; Raymund Ac Roos; Alexandra Durr; David Craufurd; Christopher Kennard; Stephen L Hicks; Nick C Fox; Rachael I Scahill; Beth Borowsky; Allan J Tobin; H Diana Rosas; Hans Johnson; Ralf Reilmann; Bernhard Landwehrmeyer; Julie C Stout
Journal:  Lancet Neurol       Date:  2009-07-29       Impact factor: 44.182

9.  Cerebral structure on MRI, Part II: Specific changes in Alzheimer's and Huntington's diseases.

Authors:  T L Jernigan; D P Salmon; N Butters; J R Hesselink
Journal:  Biol Psychiatry       Date:  1991-01-01       Impact factor: 13.382

10.  A new model for prediction of the age of onset and penetrance for Huntington's disease based on CAG length.

Authors:  D R Langbehn; R R Brinkman; D Falush; J S Paulsen; M R Hayden
Journal:  Clin Genet       Date:  2004-04       Impact factor: 4.438

View more
  51 in total

1.  Complex relationships between cerebral blood flow and brain atrophy in early Huntington's disease.

Authors:  J Jean Chen; David H Salat; H Diana Rosas
Journal:  Neuroimage       Date:  2011-09-16       Impact factor: 6.556

2.  Faulty neuronal determination and cell polarization are reverted by modulating HD early phenotypes.

Authors:  P Conforti; D Besusso; V D Bocchi; A Faedo; E Cesana; G Rossetti; V Ranzani; C N Svendsen; L M Thompson; M Toselli; G Biella; M Pagani; E Cattaneo
Journal:  Proc Natl Acad Sci U S A       Date:  2018-01-08       Impact factor: 11.205

3.  Behavioural profile of Wistar rats with unilateral striatal lesion by quinolinic acid (animal model of Huntington disease) post-injection of apomorphine and exposure to static magnetic field.

Authors:  Carolina Giorgetto; Elaine Cristina Mazzei Silva; Takae Tamy Kitabatake; Guilherme Bertolino; João Eduardo de Araujo
Journal:  Exp Brain Res       Date:  2015-02-11       Impact factor: 1.972

4.  Cortical atrophic-hypometabolic dissociation in the transition from premanifest to early-stage Huntington's disease.

Authors:  Frederic Sampedro; Saul Martínez-Horta; Jesús Perez-Perez; Andrea Horta-Barba; Diego Alfonso Lopez-Mora; Valle Camacho; Alejandro Fernández-León; Beatriz Gomez-Anson; Ignasi Carrió; Jaime Kulisevsky
Journal:  Eur J Nucl Med Mol Imaging       Date:  2019-01-09       Impact factor: 9.236

5.  Measuring and comparing brain cortical surface area and other areal quantities.

Authors:  Anderson M Winkler; Mert R Sabuncu; B T Thomas Yeo; Bruce Fischl; Douglas N Greve; Peter Kochunov; Thomas E Nichols; John Blangero; David C Glahn
Journal:  Neuroimage       Date:  2012-03-15       Impact factor: 6.556

6.  Regional atrophy associated with cognitive and motor function in prodromal Huntington disease.

Authors:  Elizabeth H Aylward; Deborah L Harrington; James A Mills; Peggy C Nopoulos; Christopher A Ross; Jeffrey D Long; Dawei Liu; Holly K Westervelt; Jane S Paulsen
Journal:  J Huntingtons Dis       Date:  2013

7.  Disruption of response inhibition circuits in prodromal Huntington disease.

Authors:  Julia A Rao; Deborah L Harrington; Sally Durgerian; Christine Reece; Lyla Mourany; Katherine Koenig; Mark J Lowe; Vincent A Magnotta; Jeffrey D Long; Hans J Johnson; Jane S Paulsen; Stephen M Rao
Journal:  Cortex       Date:  2014-06-02       Impact factor: 4.027

8.  Abnormal cerebellar volume and corticocerebellar dysfunction in early manifest Huntington's disease.

Authors:  Robert Christian Wolf; Philipp Arthur Thomann; Fabio Sambataro; Nadine Donata Wolf; Nenad Vasic; G Bernhard Landwehrmeyer; Sigurd Dietrich Süßmuth; Michael Orth
Journal:  J Neurol       Date:  2015-01-28       Impact factor: 4.849

Review 9.  Therapy development in Huntington disease: From current strategies to emerging opportunities.

Authors:  Audrey S Dickey; Albert R La Spada
Journal:  Am J Med Genet A       Date:  2017-12-08       Impact factor: 2.802

10.  Stable Atlas-based Mapped Prior (STAMP) machine-learning segmentation for multicenter large-scale MRI data.

Authors:  Eun Young Kim; Vincent A Magnotta; Dawei Liu; Hans J Johnson
Journal:  Magn Reson Imaging       Date:  2014-05-09       Impact factor: 2.546

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.